ConductScience.org, home

Paper18156458

Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.

Undas A and 3 others. Nephrol Dial Transplant, 2008. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality. Papers, record 18156458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18156458

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
PubMed
Journal
Nephrol Dial Transplant
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2008-05-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Undas AAnetta
2Kolarz MMarek
3Kopeć GGrzegorz
4Tracz WWiesława

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary ThrombosisMajor topic
FibrinMajor topic
Kidney Failure, ChronicMajor topic
Renal DialysisMajor topic
Adult
Aged
Aged, 80 and over
Blood Coagulation
Cardiovascular Diseases
Case-Control Studies
Cohort Studies
Female
Fibrin Fibrinogen Degradation Products
Fibrinolytic Agents
Humans
Long-Term Care
Male
Middle Aged
Nephelometry and Turbidimetry
Permeability
Probability
Reference Values
Risk Assessment
Statistics, Nonparametric
Survival Analysis

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
40298646Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function.Antioxidants (Basel)2025https://conductscience.org/library/papers/40298646PubMed
39765785Fibrinogen Structural Changes and Their Potential Role in Endometriosis-Related Thrombosis.Antioxidants (Basel)2024https://conductscience.org/library/papers/39765785PubMed
39477884Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation.Mol Biomed2024https://conductscience.org/library/papers/39477884PubMed
39309232Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk.Res Pract Thromb Haemost2024https://conductscience.org/library/papers/39309232PubMed
38545128Changes in fibrin clot properties in patients after Roux-en-Y gastric bypass surgery.Res Pract Thromb Haemost2024https://conductscience.org/library/papers/38545128PubMed
38431193Concerns about the application of resistance exercise with blood-flow restriction and thrombosis risk in hemodialysis patients.J Sport Health Sci2024https://conductscience.org/library/papers/38431193PubMed
34462546Comparative analysis of therapeutic effects between medium cut-off and high flux dialyzers using metabolomics and proteomics: exploratory, prospective study in hemodialysis.Sci Rep2021https://conductscience.org/library/papers/34462546PubMed
34203139Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.Int J Mol Sci2021https://conductscience.org/library/papers/34203139PubMed
34064568
Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability.
Molecules2021https://conductscience.org/library/papers/34064568PubMed
33540604Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis.Int J Mol Sci2021https://conductscience.org/library/papers/33540604PubMed
32752262Chronic Kidney Disease and Its Impact on a Prothrombotic State in Patients with Atrial Fibrillation.J Clin Med2020https://conductscience.org/library/papers/32752262PubMed
31525325Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.Transl Res2020https://conductscience.org/library/papers/31525325PubMed
30788657Nattokinase-heparin exhibits beneficial efficacy and safety-an optimal strategy for CKD patients on hemodialysis.Glycoconj J2019https://conductscience.org/library/papers/30788657PubMed
30511257Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties.J Thromb Thrombolysis2019https://conductscience.org/library/papers/30511257PubMed
28841147Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.Int J Mol Sci2017https://conductscience.org/library/papers/28841147PubMed
28279217Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.Cardiovasc Diabetol2017https://conductscience.org/library/papers/28279217PubMed
28057772Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis.J Am Soc Nephrol2017https://conductscience.org/library/papers/28057772PubMed
26905525Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.Sci Rep2016https://conductscience.org/library/papers/26905525PubMed
26592189The emerging role of coagulation proteases in kidney disease.Nat Rev Nephrol2016https://conductscience.org/library/papers/26592189PubMed
26543308Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.Med Arch2015https://conductscience.org/library/papers/26543308PubMed

See all 25 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18156458

GET https://conductscience.org/api/papers/v1/18156458/cited_by?page=2